Levetiracetam Ametas

Levetiracetam, the active ingredient in Levetiracetam Ametas, is an anticonvulsant presented as an oral tablet for oral use. It is employed to control various seizure types in patients with epilepsy, including partial, generalized tonic‑clonic, and myoclonic seizures, offering a broad spectrum of seizure management and is well‑tolerated in clinical practice.

GNH USA supplies Levetiracetam Ametas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Levetiracetam is an antiepileptic drug that acts on seizure activity across several epilepsy syndromes.

- Partial seizures: reduces seizure frequency and severity in patients with focal onset seizures. - Generalized tonic-clonic seizures: helps control convulsive episodes in individuals with generalized epilepsy. - Myoclonic seizures: diminishes rapid muscle jerks associated with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness or imbalance. - Fatigue: feeling unusually tired or weak. - Headache: mild to moderate cranial pain. - Irritability or mood changes: increased agitation or emotional lability.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or anaphylaxis. - Mood or behavioral disturbances: depression, suicidal thoughts, or aggression. - Hematologic abnormalities: low blood cell counts such as neutropenia or thrombocytopenia.

When prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure safe use. - Renal function: adjust dose in patients with impaired renal clearance. - Psychiatric history: monitor for mood changes or suicidal ideation. - Concomitant CNS depressants: use caution as additive sedation may occur. - Pregnancy and lactation: evaluate risks versus benefits before use. - Drug discontinuation: taper gradually to avoid seizure exacerbation. - Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.

Levetiracetam can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels, decreasing effectiveness. - Enzyme‑inducing antiepileptics (e.g., phenobarbital, phenytoin): can lower levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Sedative agents (e.g., benzodiazepines, alcohol): may increase central nervous system depression. - Antidepressants (e.g., SSRIs): monitor for enhanced mood changes. - Oral contraceptives: levetiracetam may slightly reduce hormonal efficacy; advise additional contraceptive measures.